TrialJapanese journal of clinical oncology2026

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

Yoshiaki Nagatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.